Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
ELISA, Bioactivity: FCM, Functional assay, Research in vivo
Human
Monoclonal
IgG1, lambda2
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
ELISA, Bioactivity: FCM, Functional assay, Research in vivo
Human
Monoclonal
IgG1, lambda
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
ELISA, Bioactivity: FCM, Functional assay, Research in vivo
Human
Monoclonal
IgG1, kappa
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
ELISA, Bioactivity: FCM, Functional assay, Research in vivo
Human
Monoclonal
IgG1, kappa
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
ELISA, Bioactivity: FCM, Functional assay, Research in vivo
Human
Monoclonal
IgG1, kappa
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
ELISA, Bioactivity: FCM, Functional assay, Research in vivo
Human
Monoclonal
IgG1
DH1047
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
ELISA, Bioactivity: FCM, Functional assay, Research in vivo
Human
Monoclonal
IgG1
002-S21F2
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
ELISA, Bioactivity: FCM, Functional assay, Research in vivo
Human
Monoclonal
IgG1, kappa
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
ELISA, Bioactivity: FCM, Functional assay, Research in vivo
Human
Monoclonal
IgG1, kappa
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
ELISA, Bioactivity: FCM, Functional assay, Research in vivo
Human
Monoclonal
IgG1, lambda2